Effect of ammonia on in vitro diaphragmatic contractility, fatigue and recovery

R. Andrew Shanely, Richard J Coast

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Following strenuous exercise, in vivo diaphragmatic strength has been reported to decrease. This decrease has been suggested to result from an increase in metabolic by-products of intense exercise. Objective: We tested the hypothesis that physiological NH3 concentrations adversely affect diaphragmatic contractility, fatigability, and recovery. Methods: Rat diaphragm strips were exposed to one of six experimental conditions (n = 6 per condition): Krebs-Ringer control solution, or the control solution with NH3 added (in mM): 0.11, 2.5, 5.0, 10.0, or 14.0. Initial diaphragmatic contractility was assessed with the force-frequency response in the control solution. Following the first force-frequency response, the solution was replaced with one of the six solutions and a second force-frequency response was measured. Strips were then subjected to a short fatigue protocol and contractility was reassessed with a third force-frequency response. A longer fatigue protocol was then administered, followed by a 20-min recovery assessment period. Results: Ammonia significantly (p < 0.05) reduced diaphragmatic contractility, but only at concentrations of 5 mM or greater. Additionally, ammonia did not alter the rate of fatigue. Conclusions: This study suggests that physiological NH3 concentrations do not adversely affect in vitro diaphragmatic contractility, fatigue, or recovery. These data are not consistent with diaphragmatic fatigue associated with exercise induced by arterial concentrations of NH3 seen in humans, although further testing in situ or in vivo is needed.

Original languageEnglish (US)
Pages (from-to)534-541
Number of pages8
JournalRespiration
Volume69
Issue number6
DOIs
StatePublished - 2002

Fingerprint

Ammonia
Fatigue
Diaphragm
In Vitro Techniques

Keywords

  • Diaphragm
  • Exercise
  • Metabolite

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Physiology

Cite this

Effect of ammonia on in vitro diaphragmatic contractility, fatigue and recovery. / Shanely, R. Andrew; Coast, Richard J.

In: Respiration, Vol. 69, No. 6, 2002, p. 534-541.

Research output: Contribution to journalArticle

@article{a5efbcef421e47a7af6ea54976d789c3,
title = "Effect of ammonia on in vitro diaphragmatic contractility, fatigue and recovery",
abstract = "Background: Following strenuous exercise, in vivo diaphragmatic strength has been reported to decrease. This decrease has been suggested to result from an increase in metabolic by-products of intense exercise. Objective: We tested the hypothesis that physiological NH3 concentrations adversely affect diaphragmatic contractility, fatigability, and recovery. Methods: Rat diaphragm strips were exposed to one of six experimental conditions (n = 6 per condition): Krebs-Ringer control solution, or the control solution with NH3 added (in mM): 0.11, 2.5, 5.0, 10.0, or 14.0. Initial diaphragmatic contractility was assessed with the force-frequency response in the control solution. Following the first force-frequency response, the solution was replaced with one of the six solutions and a second force-frequency response was measured. Strips were then subjected to a short fatigue protocol and contractility was reassessed with a third force-frequency response. A longer fatigue protocol was then administered, followed by a 20-min recovery assessment period. Results: Ammonia significantly (p < 0.05) reduced diaphragmatic contractility, but only at concentrations of 5 mM or greater. Additionally, ammonia did not alter the rate of fatigue. Conclusions: This study suggests that physiological NH3 concentrations do not adversely affect in vitro diaphragmatic contractility, fatigue, or recovery. These data are not consistent with diaphragmatic fatigue associated with exercise induced by arterial concentrations of NH3 seen in humans, although further testing in situ or in vivo is needed.",
keywords = "Diaphragm, Exercise, Metabolite",
author = "Shanely, {R. Andrew} and Coast, {Richard J}",
year = "2002",
doi = "10.1159/000066459",
language = "English (US)",
volume = "69",
pages = "534--541",
journal = "Respiration; international review of thoracic diseases",
issn = "0025-7931",
publisher = "S. Karger AG",
number = "6",

}

TY - JOUR

T1 - Effect of ammonia on in vitro diaphragmatic contractility, fatigue and recovery

AU - Shanely, R. Andrew

AU - Coast, Richard J

PY - 2002

Y1 - 2002

N2 - Background: Following strenuous exercise, in vivo diaphragmatic strength has been reported to decrease. This decrease has been suggested to result from an increase in metabolic by-products of intense exercise. Objective: We tested the hypothesis that physiological NH3 concentrations adversely affect diaphragmatic contractility, fatigability, and recovery. Methods: Rat diaphragm strips were exposed to one of six experimental conditions (n = 6 per condition): Krebs-Ringer control solution, or the control solution with NH3 added (in mM): 0.11, 2.5, 5.0, 10.0, or 14.0. Initial diaphragmatic contractility was assessed with the force-frequency response in the control solution. Following the first force-frequency response, the solution was replaced with one of the six solutions and a second force-frequency response was measured. Strips were then subjected to a short fatigue protocol and contractility was reassessed with a third force-frequency response. A longer fatigue protocol was then administered, followed by a 20-min recovery assessment period. Results: Ammonia significantly (p < 0.05) reduced diaphragmatic contractility, but only at concentrations of 5 mM or greater. Additionally, ammonia did not alter the rate of fatigue. Conclusions: This study suggests that physiological NH3 concentrations do not adversely affect in vitro diaphragmatic contractility, fatigue, or recovery. These data are not consistent with diaphragmatic fatigue associated with exercise induced by arterial concentrations of NH3 seen in humans, although further testing in situ or in vivo is needed.

AB - Background: Following strenuous exercise, in vivo diaphragmatic strength has been reported to decrease. This decrease has been suggested to result from an increase in metabolic by-products of intense exercise. Objective: We tested the hypothesis that physiological NH3 concentrations adversely affect diaphragmatic contractility, fatigability, and recovery. Methods: Rat diaphragm strips were exposed to one of six experimental conditions (n = 6 per condition): Krebs-Ringer control solution, or the control solution with NH3 added (in mM): 0.11, 2.5, 5.0, 10.0, or 14.0. Initial diaphragmatic contractility was assessed with the force-frequency response in the control solution. Following the first force-frequency response, the solution was replaced with one of the six solutions and a second force-frequency response was measured. Strips were then subjected to a short fatigue protocol and contractility was reassessed with a third force-frequency response. A longer fatigue protocol was then administered, followed by a 20-min recovery assessment period. Results: Ammonia significantly (p < 0.05) reduced diaphragmatic contractility, but only at concentrations of 5 mM or greater. Additionally, ammonia did not alter the rate of fatigue. Conclusions: This study suggests that physiological NH3 concentrations do not adversely affect in vitro diaphragmatic contractility, fatigue, or recovery. These data are not consistent with diaphragmatic fatigue associated with exercise induced by arterial concentrations of NH3 seen in humans, although further testing in situ or in vivo is needed.

KW - Diaphragm

KW - Exercise

KW - Metabolite

UR - http://www.scopus.com/inward/record.url?scp=0036446250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036446250&partnerID=8YFLogxK

U2 - 10.1159/000066459

DO - 10.1159/000066459

M3 - Article

C2 - 12457007

AN - SCOPUS:0036446250

VL - 69

SP - 534

EP - 541

JO - Respiration; international review of thoracic diseases

JF - Respiration; international review of thoracic diseases

SN - 0025-7931

IS - 6

ER -